Potential for recovery in bladder function after removing a urethral obstruction.

AIMS: We examined the relation between the loss of bladder function during obstruction and the potential for recovery of function after de-obstruction. METHODS: Guinea pigs received a partial urethral obstruction. Bladder pressure, urine flow rate, detrusor overactivity (DO), compliance and contractility were examined weekly for 2-4 weeks (short), 6-8 weeks (medium), or 9-12 weeks (long). Then the obstruction was removed and bladder function followed up to 7 weeks. The groups were compared to animals receiving only obstruction or a sham operation. RESULTS: During obstruction the three de-obstruction groups and the obstruction group progressively lost bladder function. Flow rate remained stable, compliance decreased, pressure, contractility and DO increased. After de-obstruction the response in the three de-obstruction groups varied. In S, bladder pressure and compliance normalized, contractility initially increased then decreased towards high normal values, DO remained high normal and flow rate increased. In M, bladder pressure and DO decreased to above average normal levels. Compliance improved but did not normalize. Contractility initially stabilized, then decreased to just above the normal range. Flow-rate increased. In L, bladder pressure and DO decreased to high normal. Compliance did not improve. Contractility decreased directly after de-obstruction, stabilizing at an above normal level, flow-rate increased. CONCLUSIONS: The potential for functional recovery decreases with increasing loss of bladder function. At all stages of bladder dysfunction, voiding pressure appears to normalize after de-obstruction. However, contractility remains high and compliance low. Such a bladder may be more vulnerable to new events of outflow obstruction than a low contractile, normal compliant bladder.

Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of sarcoptic mange in dogs.

A novel spot-on formulation containing metaflumizone plus amitraz (ProMeris/ProMeris Duo for Dogs, Fort Dodge Animal Health, Overland Park, KS) was evaluated for efficacy against sarcoptic mange mites in naturally infested dogs. Sixteen dogs were allocated to two equal groups and were housed individually. Eight of the dogs were treated topically with metaflumizone plus amitraz at the proposed minimum dose rate (20mg/kg of each of metaflumizone and amitraz, at a dose volume of 0.133ml/kg) on Days 0 and 28. The other eight were treated with metaflumizone plus amitraz at the proposed minimum dose rate on Days 0, 14, 28 and 42. To enumerate Sarcoptes scabiei mites, skin scrapings were taken on each of Days 2, 14, 28, 42 and 56. Clinical signs of mange and the extent of sarcoptic lesions were evaluated on each dog when scrapings were made. Evaluation of the efficacy of the treatment was based on the absence of mites supported by the absence of clinical signs associated with canine sarcoptic mange. Treatment with metaflumizone plus amitraz at the minimum proposed dose rate at monthly (two treatments) or two-weekly (four treatments) intervals resulted in a rapid reduction of mites and improved clinical signs. The overall cure rates at Day 56, based on zero mite counts and/or resolution of clinical signs were 75% and 83% of dogs for the monthly and two-weekly regimens, respectively.

Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of demodectic mange in dogs.

A novel spot-on formulation containing metaflumizone plus amitraz (ProMeris/ProMeris Duo for Dogs, Fort Dodge Animal Health, Overland Park, KS) was evaluated for efficacy against demodectic mange mites in naturally infested dogs. Sixteen dogs were allocated to two equal groups and individually housed. Eight of the dogs were treated topically with metaflumizone plus amitraz at the proposed minimum dose rate (20mg/kg of each of metaflumizone and amitraz, 0.133ml/kg) on Days 0, 28, and 56. The other eight were treated with metaflumizone plus amitraz at the proposed minimum dose rate on Days 0, 14, 28, 42, 56, and 70. Mite numbers were estimated from skin scrapings taken on Days -3 to -1, 28, 56, and 84. Clinical signs of mange and the extent of demodectic lesions on each dog were evaluated when skin scrapings were conducted. Efficacy of the treatment was based on a reduction in mite numbers and an assessment of the clinical signs associated with canine demodectic mange. Treatment at monthly or two-weekly intervals for 3 months resulted in a rapid reduction in mite numbers (>94 and >99% for the monthly and two-weekly treatments, respectively) and an improvement in clinical signs. Success rates, based on zero mite counts in skin scrapings at Day 84 were 42.9 and 62.5% of dogs for the monthly and two-weekly regimens, respectively.

Timelines of the "free-particle" and "fixed-particle" models of stone-formation: theoretical and experimental investigations.

Two major theories on renal stone formation will be reviewed, the "free-particle" and "fixed-particle" mechanisms. These theories combine data on intrinsic factors (inborn metabolic errors), extrinsic factors (diet), renal cell responses and the physico-chemistry and biochemistry of urine into mechanisms of stone formation. This paper describes the specific role of time in both mechanisms. The timeline of crystal- and stone formation was deducted from literature data and was measured for two stones using radioisotope decay analysis. The stones of similar size and composition showed, respectively, a timeline of a few years and a development that took decades. In combination with data on stone architecture and patient characteristics these timelines are explained using the free-particle and fixed-particle mechanisms. Consideration of the timeline of stone formation has clinical implications. We conclude that the fixed-particle mechanism can be a slow process where decades pass between the first formation of a precipitate in the renal interstitium and the clinical presentation of the stone. Added to the fact that the mechanism of this initial precipitation is still ill defined, the conditions that started fixed-particle stone formation in an individual patient can be obscure. Blood and urine analysis in such patients does not necessarily reveal the individual's risk for recurrence as lifestyle may have changed over time. This is in fact what defines the so-called idiopathic stoneformers. For these patients, prevention of outgrowth of previously formed precipitates, papillary plaques, may be more relevant than prevention of new plaque formation. In contrast, a patient who has formed a stone in a relatively short time through the free-particle mechanism is more likely to show abnormal values in blood and urine that explain the starting event of stone formation. In these patients, measurement of such values provides useful information to guide preventive measures.

Evaluation of the efficacy of emodepside+praziquantel topical solution against cestode (Dipylidium caninum, Taenia taeniaeformis, and Echinococcus multilocularis) infections in cats.

Emodepside+praziquantel topical solution was developed to provide broad-spectrum anthelmintic activity against gastrointestinal parasites in cats. Eight controlled studies were conducted to evaluate the efficacy of a topical solution of emodepside (3 mg/kg) and praziquantel (12 mg/kg) (Profender, BayerAG, Leverkusen, Germany) against feline infections with three species of cestodes. Studies featured naturally acquired infections of Dipylidium caninum or Taenia taeniaeformis, or experimental infections with Echinococcus multilocularis that were placebo-controlled, randomized and blinded. Cats were euthanatized and necropsied between 2 and 11 days after treatment, depending on the target parasite. The efficacy of emodepside+praziquantel topical solution was 100% against D. caninum and T. taeniaeformis, and 98.5- 100% against E. multilocularis. No significant systemic or local adverse reactions to treatment were noted in cats that received the combination. Topical treatment of cats with emodepside+praziquantel topical solution was safe and highly effective against cestode infections.

Physicochemical effects of a new slow-release potassium phosphate preparation (UroPhos-K) in absorptive hypercalciuria.

A new slow-release, neutral potassium phosphate salt (UroPhos-K) has been formulated in order to minimize gastrointestinal side effects and avoid sodium-induced calciuria. It was tested in a prospective randomized, double-blind trial in a group of 21 kidney stone patients with absorptive hypercalciuria type I (AH). Twelve patients allocated to the UroPhos-K group received four tablets twice daily with breakfast and an evening snack providing 1240 mg of phosphorus and 63.5 mEq of potassium daily. Nine patients assigned to the placebo group received placebo tablets of the same appearance containing excipient only. Subjects were studied during a 3-day period in the hospital while consuming a constant metabolic diet containing 400 mg Ca, 100 mEq Na, and 800 mg P per day before and after 3 months of treatment. Treatment with UroPhos-K did not cause any significant gastrointestinal side effects; nor did it raise fasting serum K or phosphorus, or reduce hemoglobin or creatinine clearance. It was associated with a rise in urinary K from 46 +/- 7 to 98 +/- 9 mEq per day and phosphorus from 744 +/- 185 to 1535 +/- 112 mg per day (p < 0.001 each). UroPhos-K treatment reduced urinary Ca from 288 +/- 63 to 171 +/- 49 mg/day (p < 0.001), without altering oxalate excretion. It reduced the urinary saturation of calcium oxalate without altering that of brushite. Moreover, by increasing urinary excretion of inhibitors (citrate and pyrophosphate), it reduced the propensity for spontaneous nucleation of brushite (increased formation product of brushite) and inhibited crystal agglomeration of calcium oxalate.(ABSTRACT TRUNCATED AT 250 WORDS)

The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men.

Dietary excesses in animal protein and/or salt have been implicated as risk factors in calcium oxalate urolithiasis. The underlying physicochemical mechanism is, however, not known. Eight healthy men were given four different diets varying in animal protein and in sodium content for 1 week each. On a high protein intake (2 g/kg.day) significant changes in urinary calcium, uric acid, and citrate excretion rates were found. Similar changes in calcium and citrate were induced by a high sodium intake (310 mmol/day). The changes were more pronounced when a high protein was combined with a high sodium diet. Urinary calcium increased from 3.79 +/- 0.31 to 6.42 +/- 0.61 mmol/24 h and urinary uric acid from 4.69 +/- 0.26 to 8.0 +/- 0.47, whereas urinary citrate decreased from 3.93 +/- 0.53 to 2.79 +/- 0.34 mmol/24 h. All three dietary regimens induced a significant decrease in the ability of urines to inhibit calcium oxalate monohydrate crystal agglomeration, which was most marked during the combined diet (from 345 +/- 39 to 205 +/- 28 min). The ability of urines to inhibit crystal agglomeration was related to their citrate content (r = 0.69, P less than 0.0001). These results show that high animal protein and/or sodium intake decrease the ability of urines to inhibit the agglomeration of calcium oxalate crystals and provide a possible physicochemical explanation for the adverse effects of dietary aberrations on renal stone formation.

Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium.

Interstitial calcium oxalate (CaOx) crystals can be found in primary oxalosis and in secondary hyperoxaluria. In a rat model for nephrolithiasis, we investigated whether such crystals can be removed by the surrounding interstitial cells. CaOx crystals were induced by a crystal-inducing diet based on ethylene glycol (EG) and ammonium chloride (CID). Both lithogenic compounds were added to the drinking water. After 9 days, the animals received normal drinking water for 2 days. Using this CID, only the interstitial crystals are retained. Subsequently, half of the population remained on normal drinking water (normo-oxaluria), whereas the other half received a low dose of EG alone (chronic hyperoxaluria). The rats were killed at regular times thereafter. The results showed that the kidney-associated oxalate significantly declined during normo-oxaluria, but remained high during chronic hyperoxaluria. Interstitial cells positive for the leukocyte common antigen (CD45; which identifies all types of leukocytes), the ED1 antigen (which is specific for monocytes and macrophages), and the major histocompatibility class II antigen (MCHII), respectively, had increased in number, with minor differences between both rat populations. The cells around the interstitial crystals were mostly positive for ED1. Multinucleate giant cells were regularly observed. These cells were positive for CD45 and ED1 and sometimes also for MCHII. The crystals in these cells were moderately positive for acid phosphatase and carbonic anhydrase II. It is concluded that interstitial CaOx crystals can be removed under normo-oxaluric conditions and that, in all likelihood, macrophages and multinucleate giant cells are involved in that process.

Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium.

Urinary calcium oxalate (CaOx) crystals and crystal agglomerates are normally harmlessly excreted, but in nephrolithiasis they are retained by tubular epithelial cells and shifted into the renal interstitium. This crystalline material induces an inflammatory response consisting of an increase in the number of interstitial cells and an expansion of the extracellular matrix. The newly arrived cells either derive from the blood or the connective tissue or they are formed by local proliferation. Identification of the cells that surround the interstitial crystals is a first step in investigating the question of whether the interstitial cells could remove the crystalline material. Therefore, we performed an immunohistochemical study on the kidneys of rats made hyperoxaluric by ethylene glycol (EG) and ammonium chloride (AC). Attention was paid to expression of the leukocyte common antigen (LCA), which identifies all types of leukocytes, the ED1 antigen, which is specific for monocytes and macrophages, and the major histocompatibility class II antigen (MHC II), which is present on dendritic cells, B lymphocytes, and activated macrophages. The results obtained were compared with those seen in two human kidney specimens with acute and chronic oxalosis. In both rat and humans, macrophages and multinucleated giant cells are the major cells that encapsulate the interstitial crystals. This similarity in response underlines the relevance of the rat nephrolithiasis model. The rat experiments showed, furthermore, that the number of interstitial crystals and the amount of biochemically measured kidney-associated oxalate both decrease with time, if the nephrolithiatic agents EG and AC are omitted from the drinking water. Further studies must clarify whether macrophages and multinucleated giant cells are able to remove the interstitial crystals and how these cells are recruited at the inflammatory site.

Cytokine production induced by binding and processing of calcium oxalate crystals in cultured macrophages.

Deposition of calcium oxalate (CaOx) crystals in the renal interstitium is common in humans with primary oxalosis and secondary hyperoxaluria, as well as in kidneys of rats with CaOx nephrolithiasis. In vivo, macrophages and multinucleated giant cells mostly encapsulate these crystals. To investigate whether macrophages are able to dispose of CaOx crystals after phagocytosis, we used a nontransformed macrophage cell line derived from mouse spleen progenitors. Cytokine assays showed that in response to crystal binding and phagocytosis, these macrophages release tumor necrosis factor-alpha. This release was evident at 8 hours, maximal at 24 hours, and decreased to control values after 48 hours of incubation with crystals. A very low but significant release of interleukin-6 into the culture medium was only noticed after 32 hours. Radiochemical experiments showed that these cells bind 38.8% of the CaOx crystals added. After 4 days, all internalized crystals had been dissolved and their molecular constituents released into the extracellular environment. Confocal laser scanning microscopy followed by morphometrical analyses confirmed these results. Long-term (survival) analyses showed that in the interval under study and at the crystal doses used, cell viability was not significantly affected. These findings support the view that properly functioning macrophages are able to remove CaOx deposits from the renal interstitium and that these cells produce inflammatory cytokines before crystal dissolution.

Modulation of calcium oxalate monohydrate crystallization kinetics by urine of preterm neonates.

Preterm neonates frequently develop nephrocalcinosis (NC). However, the cause has not yet been elucidated. This study focuses on the effects of urine from preterm neonates on crystallization kinetics. Urine samples were collected and renal ultrasound examinations of preterm neonates (gestational age < 32 weeks) were performed during the first weeks of life, at term, and ages 6, 12, and 24 months. The effect of urine on crystallization was determined using a seeded crystal growth system, which measures the square root of solubility product ( radicalLc), percentage of growth inhibition (GI), and agglomeration inhibition ([tm]) of calcium oxalate crystals. Data for preterm neonates in the first weeks of life (n = 19) were compared with those for full-term neonates (n = 17) and healthy adults. Moreover, the correlation between [tm] and urinary (U)citrate level was studied. Mean radicalLc (0.27 +/- 0.1 versus 0.36 +/- 0.08 mmol/L) and mean [tm] (81 +/- 32 versus 143 +/- 97 minutes) were lower and mean Ucalcium-creatinine (2.20 +/- 1.74 versus 0.46 +/- 0.73 mol/mol) and Uoxalate-creatinine ratios (0.39 +/- 0.21 versus 0.16 +/- 0.09 mol/mol) were greater in preterm neonates in the first weeks of life compared with full-term neonates (p < 0.05). Furthermore, [tm] was less than the lower limit for healthy adults for all but one preterm neonate; [tm] increased and Ucalcium-creatinine and Uoxalate-creatinine ratios decreased with age (p < 0.005). There was a correlation between [tm] and citrate excretion (coefficient of 38; P < 0.001). Patients with and without NC at term did not differ statistically in mean radicalLc, percentage of GI, or [tm]. In conclusion, urine from preterm neonates in the first weeks of life is highly supersaturated and has a defective ability to inhibit calcium oxalate crystal agglomeration. This ability improves with age and is citrate mediated. We suggest that both the high level of supersaturation and defective ability to inhibit calcium oxalate crystal agglomeration contribute to the high incidence of NC.

Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.

OBJECTIVES: The agglomeration of preformed crystals of calcium oxalate has been hypothesized to be the rate-limiting step in renal stone-forming activity (SFA). The effect of urine on the in vitro inhibition of agglomeration of seed crystals of calcium oxalate monohydrate, designated [tm], has been used to monitor SFA in calcium oxalate stone formers (CaOxSF). The objective of the present study was to determine whether [tm] could be used to help monitor the long-term effectiveness of oral potassium citrate therapy (K-Cit-Rx) in CaOxSF. METHODS: Clinic and radiographic (or ultrasound) reports were evaluated for 80 patients, aged 20 to 72 years, 55 men and 25 women, who were treated with oral K-Cit for recurrent calcium oxalate urolithiasis at the Ochsner Stone Clinic between January 1992 and July 1996. Seventy-five of these patients had at least one 24-hour citrate excretion rate of less than 3.0 mm/day before or after K-Cit-Rx. SFA graded on a scale of -2 to +2 by radiographic criteria was combined with information on stone passage to evaluate clinical stone status, and 24-hour urine collections were evaluated for volume, pH, calcium, citrate, uric acid, oxalate, creatinine, and [tm] on free diet before and after 6 to 53 months of K-Cit-Rx. Historical information on procedures performed for urolithiasis before and on K-Cit-Rx was also reviewed. RESULTS: K-Cit-Rx resulted in increased urine pH (P <0.0001) and decreased calcium (P=0.0475), [tm] (P=0.0045), number of stones passed per year (P=0.0016), and remedial procedures per year (P <0.0001). Patients taking allopurinol in addition to K-Cit required higher doses (P <0.0001) of K-Cit to control their disease, had lower pretreatment urine pH (P=0.0493), and showed greater increase in urine citrate (P=0.0092) than those on K-Cit alone. Those taking high-dose K-Cit were younger (P=0.0363) and showed greater decrease in SFA (P=0.0005) than those taking lower doses. A small group of 10 medication refractory patients, who retained (n=9) or increased (n=1) their stone burden during K-Cit-Rx, was identified. Compared with the medication-responsive group, the refractory patients were older (P=0.0124), and had greatly increased SFA (P <0.0001) and higher (P=0.0347) urine pH before and during (P=0.0173) treatment (data not shown). CONCLUSIONS: The data confirm that [tm] can be used not only to verify previously documented stone formation rate but also to help evaluate the long-term effectiveness of therapy. In this report, changes in [tm] after K-Cit-Rx reflected decreased stone formation rate and decreased remedial procedures.

Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.

OBJECTIVES: To evaluate the effect of oral potassium citrate therapy on urinary excretion rates of citrate. Tamm-Horsfall protein (THP), and on calcium oxalate monohydrate crystal agglomeration inhibition [tm], in patients with recurrent calcium stone formation. METHODS: To evaluate the effect of oral therapy with potassium citrate on urinary citrate, THP, and [tm], 24-hour urine samples were collected before and at least 2 months after initiation of oral potassium citrate therapy in 33 calcium stone-forming patients who had no dietary restrictions. The citrate concentration was measured by an adaptation of a citrate lyase method. Urinary disaggregated THP concentration was determined with a quantitative enzyme-linked immunosorbent assay. The [tm] was determined by observing the effects of patients' urine, before and after oral potassium citrate therapy, on the uptake of 45Ca2+ onto the surfaces of added preformed calcium oxalate crystals in a supersaturated solution of calcium oxalate, using the in vitro kinetic method described by other investigators. RESULTS: We observed an increased urinary excretion rate of citrate from a mean of 1.9 mmol/24 h prealkali to 2.6 mmol/24 h postalkali (P < 0.0004) and of THP from a mean of 94.0 mg/24 h prealkali to 199.3 mg/24 h postalkali (P < 0.0016). A corresponding increase in [tm] from a mean of 177.1 minutes prealkali to 221.0 minutes postalkali (P < 0.024) was also observed. CONCLUSIONS: To our knowledge this is the first report correlating increased urinary citrate with THP excretion rate following oral alkalinization with potassium citrate in calcium stone formers. Of clinical importance is the corresponding increase in [tm], which was previously shown to be inversely related to stone-forming activity. Moreover, urinary citrate and THP are known to have a synergistic effect on [tm]. Our data suggest that the effectiveness of potassium citrate therapy in calcium stone-forming patients may, at least in part, be due to increased levels of THP.

The efficacy of Diflubenzuron against the body louse (Damalinia limbata) of Angora goats.

The efficacy of an insect growth regulator, Diflubenzuron, to control biting lice (Damalinia limbata) on Angora goats was investigated. Lice on goats which were dipped in a concentration of 625 g Diflubenzuron to 1,000 1 water and then kept in quarantine was eradicated after a single treatment. Nymphs remained present on these goats up to 4 weeks and adult lice up to 8 weeks post-treatment. A single treatment provided greater than 90% reduction in nymphal stages from Week 6 to Week 16 post-treatment in treated goats continuously exposed to reinfestation. The treatment reduced adult louse infestations on these goats by 78-94% through Weeks 6-16 post-treatment. At the end of the trial (24 weeks post-treatment), these goats had 88% fewer nymphs and 84% fewer adult lice compared with untreated control goats.

Interbreed differences in the efficacy of 1% deltamethrin pour-on to protect small livestock against infestation with Ixodes rubicundus (Acari:Ixodidae).

Synthetic pyrethroid pour-on compounds have been developed for use on cattle but many are now also registered for the control of ectoparasites on small ruminants. The breed of small livestock has been known to influence the efficacy of various pour-ons and we hypothesized that differences in the duration of protection afforded by a synthetic pyrethroid pour-on against ticks on small livestock, would be greatest between hairy and woolly breeds. Angora goats with mohair, Dorper sheep with hairy wool, and Merino sheep with wool were treated with 1% m/v deltamethrin pour-on with an oil base at a dosage rate of 1 ml 5 kg-1 body mass. The duration of effective protection against Ixodes rubicundus, the Karoo paralysis tick, was determined under field conditions. Angora goats proved to be the highest risk group, but were afforded the least protection. Efficacy never reached 100% in this group and within 3 weeks the goats were already at risk of paralysis. Dorper sheep were afforded above 90% protection for 3 weeks and 85% after 4 weeks. In the case of the Merino sheep efficacy of protection remained above 90% up to 7 weeks post-treatment and was still 87% during Week 8. Differences in the amount of sebum and suint in the epidermis of the different breeds may be responsible for differences in the rate of spread and the rate of dilution of the active compound in the epidermis.

The role of Hyalomma ticks in foot infestations and temporary lameness of sheep in a semi-arid region of South Africa.

An outbreak of lameness amongst Merino lambs, associated with the presence of Hyalomma ticks, was investigated on a farm in the south-western Free State, South Africa. The purpose was to follow the progress of the condition and to determine the extent of involvement of the two Hyalomma species which occur in the region. The flock of experimental sheep (n = 460) ranged free in natural veld under extensive farming conditions. During September and October 1993, adult ewes and lambs in this flock were examined at weekly intervals to determine tick identity, abundance and attachment-site preferences on lame and unaffected animals. Lameness occurred only among lambs, of which 68 were affected during the 8-week period. Hyalomma ticks tended to aggregate and mean numbers of ticks/aggregation were significantly higher on lame lambs (mean = 11.3) than on either the unaffected lambs (mean = 6.9) or the ewes (mean = 7.1). Most tick aggregations (72.4%) on the lame lambs occurred on the lower legs and feet, 34 out of 55 of these on the fetlocks or interdigital clefts. Hyalomma truncatum dominated (> 97%) on all animals examined. Only 15.8% of the Hyalomma marginatum rufipes recovered from the lame animals were attached to the legs. At two other localities at which H. marginatum rufipes was more abundant, or even dominant, few ticks attached to the lower legs or feet. Those that did were mostly H. truncatum (> 90%). Both H. marginatum rufipes and H. truncatum may attach to the same ventral and anogenital body regions, but H. truncatum has a tendency to attach also to the feet and lower legs. Although attachment of one or a few ticks in the axillar region or upper legs may cause lameness in sheep, the attachment of ticks to the interdigital clefts and fetlocks almost always causes lameness. The latter condition is more likely to occur in regions where H. truncatum dominates.

Attachment preferences of Hyalomma truncatum and Hyalomma marginatum rufipes ticks (Acari: Ixodidae) on two sheep breeds.

Hyalomma ticks were collected from Merino and black-headed Dorper sheep and their attachment preferences determined. The preferred site of attachment for Hyalomma marginatum rufipes on both Dorper and Merino sheep was the anogenital and inguinal areas (75-76%). On Dorper sheep, H. truncatum attached predominantly to the anogenital and inguinal areas (67.7%). On Merino sheep, most adults of this species attached to the feet (26%). Almost equal percentages also attached to the anogenital/inguinal and brisket areas (21.6 and 22.9%, respectively). These differences should be considered when pour-on acaricides are applied to different breeds of sheep.

Seasonal dynamics of the Karoo paralysis tick (Ixodes rubicundus): a comparative study on Merino and Dorper sheep.

Karoo paralysis in South Africa is induced in livestock by feeding female Ixodes rubicundus ticks when infestation densities on hosts exceed certain critical levels. It has been shown previously that Angora goats are at a higher risk of being paralysed than Merino sheep, and such differences have been related to differences in feeding behaviour and spatial distribution of the two small-stock breeds. We hypothesized that differences in infestation densities with Karoo paralysis ticks would also occur between Merino and Dorper sheep breeds. A study was conducted under natural conditions in the south-western Free State, to compare infestation burdens of the two sheep breeds and also to investigate seasonal patterns and annual variations in variations in terms of rainfall and temperature. Ten animals of each breed ran free in an area with a known history of Karoo paralysis and were examined on an approximately fortnightly basis, from March 1992 to December 1995, to determine tick abundance. Differences between the two breeds were significant (P < 0.05) during 1992 and 1993, but not during 1994. During the first two years, peak abundance of ticks was reached earlier in Dorper than in Merino sheep, and it also reached higher levels in Dorper than in Merino sheep (mean = 17.9 and 7.3, respectively). In 1993, two Dorper, but no Merino sheep, were paralysed. Dorper sheep are clearly at a higher risk of being paralysed than are Merino sheep, and as such, they can serve as indicators of adult tick activity and hence of the time to commence prophylactic treatment. Differences between the two breeds are probably related to differences in grazing patterns. Marked variation in abundance and the time of onset of peak activity of I. rubicundus occurred over the years. Tick numbers were high in 1993 and 1995, but very low in 1992. In 1993, peak activity occurred earlier (April) than during the other years (June or July). These differences are related to differences in prevailing environmental conditions that influence tick activity in a complex manner. Heightened humidity and lower temperatures during the early stages of seasonal activity of the tick (April or May), normally result in peak abundance of ticks on hosts at that time.

Adult ixodid ticks on two cattle breeds in the south-western Free State, and their seasonal dynamics.

A study was conducted to compare the species of adult ixodid ticks on Friesian and Bonsmara cattle and their seasonal dynamics. Between five and ten animals of each breed were kept on natural False Upper Karoo vegetation, typical of the south-western Free State. Between May 1990 and October 1991, the animals were examined once or twice a month for the presence of adult ticks which were removed, counted and identified. Six species of ixodid ticks were recorded. The species composition on the two cattle breeds was remarkably similar. Ixodes rubicundus was dominant (55-57.7% of all ticks collected), followed by Hyalomma marginatum rufipes (28.9-31.5%) and Rhipicephalus punctatus *6.2-6.7%). Only small numbers of Hyalomma truncatum, Rhipicephalus evertsi evertsi and Rhipicephalus gertrudae were recorded. Almost twice as many ticks were collected from Friesian as from Bonsmara cattle. Ixodes rubicundus showed a typical winter-activity period. The other species were either active mostly during the warmer months, or their numbers were to low to determine any seasonal pattern. Apart from information on the diversity of ticks which infest cattle in the region, the study has also shown a greater resistance by Bonsmara cattle (a mixed Bos taurus/Bos indicus breed) to tick infestation. Bos indicus cattle can play an increasingly important role in integrated tick-management practices in southern Africa.

Assessment of cattle owner's perceptions and expectations, and identification of constraints on production in a peri-urban, resource-poor environment.

This questionnaire survey was conducted amongst 200 farmers in the resource-poor, urban and per-urban environments of Botshabelo and Thaba Nchu towns in the Free State Province of South Africa. The questionnaire was divided into seven sections, namely demography, livestock, cattle, parasites, parasite control, livestock diseases and problems experienced. A total of 87.5% of the livestock owners were not employed (unemployed or pensioner). Cattle constituted more than 50% of the live-stock units owned in the area and farmers owned an average of 9.33 +/- 0.812 head of cattle. A total of 193 (96.5%) of the farmers indicated that milk was the most important product from their cattle. Only 26% of them slaughtered their own cattle for meat consumption. Eighty-eight percent of them indicated that external parasites on their livestock presented a problem, but only 72.9% of farmers implemented any tick control measures. Less than half (45.5%) of the farmers who attempted to control ticks used commercial acaricides. The remainder used various other methods, including the application of used engine oil and household detergents. Amongst the clinical diseases observed in their cattle, dry gallsickness was mentioned most often (20%). This figure, however, is believed to be inaccurate because dry gallsickness may be a clinical manifestation of some of the other diseases mentioned by the farmers, such as anaplasmosis, foreign body obstruction of the gastro-intestinal tract by plastic bags, pneumonia and mastitis. Animal husbandry problems experienced by the farmers included pollution (i.e. ingestion of plastic bags and string by their livestock), availability of water and theft.